[HEMOGLOBIN A1C AND MORTALITY FROM COVID-19].

Merzon, Eugene; Green, Ilan; Shpigelman, Miriam; Vinker, Shlomo; Raz, Itamar; Golan-Cohen, Avivit; Eldor, Roy

Merzon, Eugene; Green, Ilan; Shpigelman, Miriam; Vinker, Shlomo; Raz, Itamar; Golan-Cohen, Avivit; Eldor, Roy.

Afiliación

Merzon E; Leumit HMO, Medical Division, Tel-Aviv, Israel.
Green I; Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University.
Shpigelman M; Leumit HMO, Medical Division, Tel-Aviv, Israel.
Vinker S; Leumit HMO, Central District Headquarter, Netanya, Israel.
Raz I; Leumit HMO, Medical Division, Tel-Aviv, Israel.
Golan-Cohen A; Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University.
Eldor R; The Pesach Segal Israeli Center for Diabetes Research and Policy, Sheba Medical Center, Ramat Gan, Israel.

Harefuah ; 160(10): 645-650, 2021 Oct.

Article en He | MEDLINE | ID: mdl-34689433

Asunto(s)

COVID-19; Estudios de Casos y Controles; Hemoglobina Glucada/análisis; Humanos; Estudios Retrospectivos; SARS-CoV-2

Buscar en Google

Imprimir

XML

PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: He Revista: Harefuah Año: 2021 Tipo del documento: Article País de afiliación: Israel

Buscar en Google

Imprimir

XML

PubMed Links